Pre-earnings brief
Reports
Thu, Nov 5, 2026
Est. EPS
—
Est. revenue
—
Implied move
±13.8%
EPS beat rate
63%
LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery. As a company with a market cap of $2 billion, it plays a crucial role in providing innovative solutions for vascular health, which is increasingly important as the global population ages.
Last quarter
In Q2 2026, LeMaitre reported an EPS of $0.74, falling short of expectations by 8.07%. The stock reacted positively, gaining 2.09% the following day.
EPS beat streak
0Q
EPS beat rate
63%
Avg EPS surprise
+1.94%
Avg 1-day reaction
-0.05%
Investors are cautiously optimistic ahead of the earnings report, given the company's history of beating EPS estimates. However, the recent miss has raised concerns about future performance.
Bull case
If LeMaitre can deliver strong revenue growth and exceed EPS expectations, it could signal a recovery and renewed investor confidence.
Bear case
Conversely, if the company misses again, it may indicate deeper issues with product demand or market competition, leading to a negative reaction.
Key metrics to watch
Earnings Per Share (EPS)
$0.81EPS is a key indicator of the company's profitability and will help gauge how well it has performed compared to analyst expectations.
Revenue Growth
N/ARevenue growth is essential for understanding the company's market position and demand for its products.
The print will turn on these.
Q1
Will EPS exceed $0.81 this quarter?
A beat on EPS would demonstrate improved profitability and could boost investor confidence after the recent miss.
Q2
What is the outlook for revenue growth?
Understanding revenue trends will provide insight into market demand and the company's competitive position.
Est. EPS
$1.98
Est. Rev
$113.6B
Impl. Move
±4.0%
Why consensus could be wrong
The Street may be underestimating the potential for LeMaitre to rebound from its recent miss, as historical patterns show a tendency for the stock to recover quickly after similar situations.
Supporting evidence
The options market is pricing a significant move, indicating that traders expect volatility and potential upside.
LeMaitre has a history of beating EPS estimates, which could suggest a stronger performance than anticipated.
Key risk
If EPS comes in below $0.74, it could validate bearish sentiments and lead to a significant sell-off.
Pre-commit to what would confirm each case.
The market is weighing the potential for recovery against the risk of further misses, making this earnings report critical.
Bull confirmed if
Delivering an EPS of $0.81 or higher would confirm the bull case.
Bear confirmed if
An EPS below $0.74 would reinforce concerns about the company's performance.
What the market is pricing for the move.
Implied Move
±13.8%
Historical Avg
±1.2%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±13.8% while LMAT has averaged ±1.2% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
20.1%
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing rich setup in Health Care
Fade rate: 13 of 30 (43%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 30 faded and 17 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.6%, with a raw directional average of +2.0% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
103.93%
of float
Insider
6.52%
of float
Holders
443
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
3,272,973 sh · $259.6M
14.31%
4.1%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If LeMaitre beats expectations, history suggests a potential stock increase of around +0.21%, which would confirm a positive outlook.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors assess management's commentary.
Miss
A miss could lead to a decline of about -0.50%, reflecting ongoing concerns about the company's growth trajectory.
The lines on the call that would change the story.
Conestoga Capital Advisors, LLC
1,367,513 sh · $108.5M
5.98%
-7.4%
First Trust Advisors LP
1,093,502 sh · $86.7M
4.78%
9.6%
Congress Asset Management Co
961,514 sh · $76.3M
4.20%
-0.2%
Vanguard Capital Management LLC
953,437 sh · $75.6M
4.17%
4.5%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.